Site icon Facet Life Sciences

ICYMI – Q2 2024 – Psychedelic Therapeutics & Drug Development Conference

Facet Attends Psychedelic Therapeutics & Drug Development Conference

In May, Dr. Jason Mercer attended the Psychedelic Therapeutics & Drug Development Conference.  This conference brought together academic and industry experts in the field of psychedelic therapeutics.  Conference presentations included discussions of early stage psychedelic therapeutic products, research into the mechanisms of action of psychedelic therapeutics in a variety of disorders.  It was a great opportunity to interact with other professionals in this exciting area of therapeutic products.  



Exit mobile version